Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival.

about

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy.

P2860

Q55118858-C0EF32F9-39AD-412A-AF8B-4D6D6750D20E

P2860

Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival.

Item

http://www.wikidata.org/entity/Q38620741

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Prostate-specific antigen afte ...... me including overall survival.

@en

type

Item

label

Prostate-specific antigen afte ...... me including overall survival.

@en

prefLabel

Prostate-specific antigen afte ...... me including overall survival.

@en

P1476

Prostate-specific antigen afte ...... me including overall survival.

@en

P2093

Alessandra Siegmann

http://www.w3.org/2001/XMLSchema#string

Detlef Bartkowiak

http://www.w3.org/2001/XMLSchema#string

Dirk Bottke

http://www.w3.org/2001/XMLSchema#string

Dirk Böhmer

http://www.w3.org/2001/XMLSchema#string

Reinhard Thamm

http://www.w3.org/2001/XMLSchema#string

Thomas Wiegel

http://www.w3.org/2001/XMLSchema#string

Volker Budach

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial

Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen.

Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10.

Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy.

Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.

Radiotherapy after prostatectomy: is the evidence for dose escalation out there?

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

Very Early Salvage Radiotherapy Improves Distant Metastasis-Free Survival.

The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0284186X.2017.1364869

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28816074

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival.

about

P2860

P2860

Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698

P921